Back to top

TransMedics initiated with a Neutral at UBS

UBS initiated coverage of TransMedics (TMDX) with a Neutral rating and $80 price target Published first on TheFly – the ultimate source for real-ti...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

TransMedics Group, Inc. (TMDX)